Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01286987
Title Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioMarin Pharmaceutical
Indications

pancreatic cancer

lung small cell carcinoma

Ewing sarcoma

ovarian cancer

prostate cancer

Advanced Solid Tumor

breast cancer

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.